Like all complex organisms, every human originates from a single cell that multiplies through countless cell divisions.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced 24-week post-end of treatment data from Part B of the ongoing MARCH Phase 2 clinical study evaluating t ...

A study released in December of 2024 has found that drones not only can provide rural residents with access to healthcare resources, but that rural people are eager to embrace the new technology.

Vir Biotechnology, Inc. VIR announced new encouraging preliminary data from its phase II SOLSTICE study. Its shares rose 19.7% on the news.

Biotechnology comprises the study and manipulation of living organisms with the goal of creating new products and processes that can improve our health and/or standards of living. It’s a field ...

Shares of Sana Biotechnology jumped after the company reported positive results for the latest study transplanting its UP421 cell therapy into a patient with type 1 diabetes. The stock was up 21% at ...

Shares of Vir Biotechnology VIR plunged 44.90% after the company announced that the mid-stage PENINSULA (PrevEntioN of IllNesS DUe to InfLuenza A) study evaluating VIR-2482 for the prevention of ...

Unity diabetes study showing durable vision gains with full 36-week data expected in Q2 ... Unity Biotechnology, Inc. UBX stock plummeted on Monday after the company released results from its ...

Our BSc Biotechnology with Entrepreneurship degree enables you to improve your business innovation skills and spend a year on placement. ... Study abroad. Industry placements are available at home and ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced 24-week post-end of treatment data from Part B of the ongoing MARCH Phase 2 clinical study evaluating tobevibart and elebsiran without or with ...